<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Five Questions with Merrill Goozner</title>
	<atom:link href="/edsblog/five-questions-with-merrill-goozner/feed/" rel="self" type="application/rss+xml" />
	<link>/edsblog/five-questions-with-merrill-goozner/</link>
	<description>Helping Americans get safe access to affordable medications.</description>
	<lastBuildDate>Thu, 10 Jan 2013 22:30:51 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.1</generator>
	<item>
		<title>By: eDrugSearch Blog &#187; Blog Archive &#187; FDA still trying to scare people away from online pharmacies</title>
		<link>/edsblog/five-questions-with-merrill-goozner/comment-page-1/#comment-12318</link>
		<dc:creator>eDrugSearch Blog &#187; Blog Archive &#187; FDA still trying to scare people away from online pharmacies</dc:creator>
		<pubDate>Mon, 19 Feb 2007 07:32:12 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/five-questions-with-merrill-goozner/#comment-12318</guid>
		<description>[...] As for the FDA&#8217;s agenda? We&#8217;re reminded of what Merrill Goozner told us in our recent chat with him: I always find it curious that free traders are worried about the safety of drugs imported from Canada, but not lettuce from Mexico. I suspect Canadaâ€™s system for protecting its consumers against unsafe drugs is far superior to Mexicoâ€™s system for protecting consumers against contaminated food. [...]</description>
		<content:encoded><![CDATA[<p>[...] As for the FDA&#8217;s agenda? We&#8217;re reminded of what Merrill Goozner told us in our recent chat with him: I always find it curious that free traders are worried about the safety of drugs imported from Canada, but not lettuce from Mexico. I suspect Canadaâ€™s system for protecting its consumers against unsafe drugs is far superior to Mexicoâ€™s system for protecting consumers against contaminated food. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: sarahparkin.com &#187; Interview with the Gooz</title>
		<link>/edsblog/five-questions-with-merrill-goozner/comment-page-1/#comment-8374</link>
		<dc:creator>sarahparkin.com &#187; Interview with the Gooz</dc:creator>
		<pubDate>Thu, 08 Feb 2007 15:51:24 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/five-questions-with-merrill-goozner/#comment-8374</guid>
		<description>[...] Over at eDrugSearch is a brief and excellent interview with Merrill Goozner, journalist and author of the great book, the $800 Million Pill. There are so many quotable quotes in the interview that I&#8217;m tempted to steal them all. Instead, I&#8217;ll leave you with just one teaser: Goozner: If half of industry R&amp;D is spent on developing drugs that add little or nothing to physiciansâ€™ ability to fight disease, and a substantial portion of industry marketing costs go to promote these drugs, or to whatever extent this is true, then the cost of drugs could be reduced by that amount without any harm to public health. Indeed, I would argue that eliminating these wasteful expenditures would free up industry resources to pour into more speculative (difficult) R&amp;D projects&#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Over at eDrugSearch is a brief and excellent interview with Merrill Goozner, journalist and author of the great book, the $800 Million Pill. There are so many quotable quotes in the interview that I&#8217;m tempted to steal them all. Instead, I&#8217;ll leave you with just one teaser: Goozner: If half of industry R&amp;D is spent on developing drugs that add little or nothing to physiciansâ€™ ability to fight disease, and a substantial portion of industry marketing costs go to promote these drugs, or to whatever extent this is true, then the cost of drugs could be reduced by that amount without any harm to public health. Indeed, I would argue that eliminating these wasteful expenditures would free up industry resources to pour into more speculative (difficult) R&amp;D projects&#8230; [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
